Eric S. Daar, MD
Professor of Medicine
David Geffen School of Medicine at UCLA
Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Los Angeles, CA

Research Topics

Lecture and Writing Topics

• American Medical Association
• American Academy for the Advancement of Sciences
• American Society of Microbiology
• IAS–USA
• Medical Director, Heart Touch Foundation
• Chief Medical Advisor, Positive Living for US (PLUS)
• Board of Directors, AIDS Project Los Angeles
• Executive Committee, AIDS Project Los Angeles
• American Academy of HIV Medicine
• HIV Medicine Association
• HIV Disease Research Agenda Committee, AIDS Clinical Trials Group
• Hepatology Research Agenda Committee, AIDS Clinical Trials Group
  
  

Honors and Awards

• Alpha Omega Alpha Medical Society, Beta Chapter, Washington, D.C. (1984)
• Ben Newman Award for Resident Achievement, Cedars-Sinai Medical Center (1988)
• Morris Press Humanism Award for Attending Staff, Cedars-Sinai Medical Center (1994)
• Golden Apple Award for Teaching Excellence, Cedars-Sinai Medical Center (1995, 1998)
• UCLA School of Medicine Award for Excellence in Education (2000)
• LA Shanti Plus Program Pat Griffin Hero of the Year (2003)
  
  

Education

• UCLA, BA Biology (1981)
• Georgetown School of Medicine, MD (1985)
• Cedars-Sinai Medical Center/UCLA Medical Center, Residency (1985-1988)
• Cedars-Sinai Medical Center, Fellowship in Infectious Diseases (1988-1991)
  
  

Selected Publications

1. Daar ES, Little SJ, Pitt J, Ho P, Harawa N, Kerndt P, Giorgi JV, Bai J, Gaut P, Richman DD, Mandell S, Nichols S; Los Angeles County Primary HIV Infection Recruitment Network. Diagnosis of primary HIV infection. Ann Intern Med. 2001;134:25-29.
2. Daar ES, Lynn H, Donfield S, Gomperts E, Hilgartner MW, Hoots WK, Chernoff D, Arkin S, Wong WY, Winkler CA; Hemophila Growth and Development Study. Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs. J Infect Dis. 2001;183:589-595.
3. Daar ES, Lynn H, Donfield S, Gomperts E, Hilgartner MW, Hoots WK, Chernoff D, Arkin S, Wong WY, Winkler CA; Hemophilia Growth and Development Study. Relation between HIV-1 and hepatitis C viral load in patients with hemophilia. J Acquir Immun Defic Syndr. 2001;26:466-472.
4. Forthal DN, Landucci G, Daar ES. Antibody from patients with acute HIV infection inhibits primary strains of HIV-1 in the presence of natural killer effector cells. J Virology. 2001;75:6953-6961.
5. Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, Koup RA, Margolick JB, Connick E, Whitcomb JM, Hellmann NS, Richman DD. Antiretroviral drug resistance among patients recently infected with HIV. N Engl J Med. 2002;347:385-394.
6. Daar ES. Antiretroviral resistance in clinical practice. J Int Assoc Physicians AIDS Care (Chic Ill). 2003;2:S4-S18.
7. Leigh Brown AJ, Frost SD, Good B, Daar ES, Simon V, Markowitz M, Collier AC, Connick E, Conway B, Margolick JB, Routy JP, Corbeil J, Hellmann NS, Richman DD, Little SJ. Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection. J Virol. 2004;78:2242-2246.
8. Moyle GJ, Daar ES, Gertner JM, Kotler D, Melchior J-C, O'Brien F, Svanberg E, on behalf of the Serono 9037 Study Team. Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy. J Acquir Immun Defic. 2004;35:367-375.
9. Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Daar ES, Richman DD, Little SJ. The incidence of HIV superinfection following primary infection. JAMA. 2004;292:1177-1178.
10. Yoo TW, Donfield S, Lail A, Lynn HS, Daar ES; Hemophilia Growth and Development Study. Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease. J Infect Dis. 2005;191:4-10.